To Evaluate the Efficacy and Safety in Patients With Dyslipidemia and Hypertension

NCT05331014 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

155

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemia
Hypertension

Interventions

DRUG: LivaloVA
DRUG: LivaloV
DRUG: VA

Sponsor

JW Pharmaceutical